Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis (Q34894822)

5 August 2017

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis (English)

1 reference

5 August 2017

1 reference

Maria L E Andersson

1

1 reference

5 August 2017

Björn Svensson

2

1 reference

5 August 2017

Ingemar F Petersson

3

1 reference

5 August 2017

Ingiäld Hafström

4

1 reference

5 August 2017

Kristina Albertsson

5

1 reference

5 August 2017

Kristina Forslind

6

1 reference

5 August 2017

Dick Heinegård

7

1 reference

5 August 2017

Tore Saxne

8

1 reference

5 August 2017

2 August 2013

1 reference

BMC Musculoskeletal Disorders

5 August 2017

1 reference

5 August 2017

14

1 reference

5 August 2017

229

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-14-229

5 August 2017

0 references

cites work

Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Predictors for remission in rheumatoid arthritis patients: A systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Fell-Muir Lecture: Proteoglycans and more--from molecules to biology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments

8 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

8 July 2018

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Within-subject biological variation in disease: collated data and clinical consequences.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

8 July 2018

DAS remission cut points

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Prognostic laboratory markers of joint damage in rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Integration of data derived from biological variation into the quality management system.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Joint damage and disability in rheumatoid arthritis: an updated systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750296

Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year contin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Serum biologic markers as predictors of disease progression in osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

The heritable determinants of cartilage oligomeric matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-14-229

Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression

21 January 2018

1 reference

12 December 2020

Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis

1 reference

12 December 2020

Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy

1 reference

12 December 2020

Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis

1 reference

12 December 2020

Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire

1 reference

12 December 2020

Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage

1 reference

12 December 2020

Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood

1 reference

12 December 2020

Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint

1 reference

12 December 2020

Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet

1 reference

12 December 2020

Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint

1 reference

12 December 2020

Biological variation of Cartilage Oligomeric Matrix Protein (COMP): A proposal to interpret laboratory serial testing

1 reference

12 December 2020

Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression

1 reference

12 December 2020

Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing

1 reference

12 December 2020

How to read radiographs according to the Sharp/van der Heijde method

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2474-14-229

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference